Aire controls mesenchymal stem cell-mediated suppression in chronic colitis

Area of Science:

• Immunology
• Stem Cell Biology
• Molecular Biology

Background:

• Mesenchymal stem cells (MSCs) show promise as immunotherapeutics due to their ability to suppress T lymphocytes.
• The intrinsic molecular mechanisms governing MSC immunomodulation, particularly transcriptional regulation, are not fully understood.
• Understanding MSCs' intrinsic programming is crucial for optimizing their clinical application in inflammatory and autoimmune diseases.

Purpose of the Study:

• To identify the intrinsic transcriptional switch responsible for programming MSCs towards an immunomodulatory phenotype.
• To investigate the role of the transcriptional regulator Aire in MSC-mediated suppression of T cell pathogenesis.
• To elucidate the molecular mechanism by which Aire influences MSC function in autoimmune conditions.

Main Methods:

• Utilized a mouse model of chronic colitis to assess MSC function in vivo.
• Investigated the effect of Aire deficiency on MSC-mediated T cell suppression in vitro and in vivo.
• Analyzed the regulation of the pro-inflammatory cytokine early T cell activation factor (Eta)-1 by Aire in MSCs.

Main Results:

• Bone marrow-derived MSCs require the transcriptional regulator Aire to suppress T cell-mediated pathogenesis in chronic colitis.
• Aire deficiency in MSCs did not impair their ability to suppress T cell proliferation in vitro.
• Aire negatively regulates Eta-1, a pro-inflammatory cytokine, thereby reducing T cell mitochondrial reductase activity.

Conclusions:

• Aire acts as an early molecular switch that imposes a suppressive MSC phenotype through Eta-1 regulation.
• Neutralizing Eta-1 rescues the ameliorative capacity of Aire(-/-) MSCs in a colitis model.
• Monitoring Aire expression in MSCs is proposed as a critical parameter for their clinical use in immunotherapy.